Company Filing History:
2 out of 5 
1 out of 1 Years Active: 2009-2013
Title: Innovations of Jean L Santos
Introduction
Jean L Santos is a notable inventor based in Araraquara, Brazil. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 2 patents, Santos has focused on developing compounds with therapeutic applications.
Latest Patents
Santos's latest patents include "Compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these." This invention relates to compounds derived from taurine that exhibit non-steroidal anti-inflammatory activity. The first embodiment describes compounds where taurine is directly bound by an amide bond or through a spacing group to a non-steroidal anti-inflammatory compound. The second embodiment outlines a process for obtaining these compounds through the reaction of taurine with non-steroidal anti-inflammatory agents. Additionally, he has patented "Antibacterial and/or antiprotozoal nitromidazole derivative compounds with urease inhibitor activity, process for preparing these compounds and use in pharmaceutical compositions and medicines." This application details nitroimidazolic derivative compounds that serve as potent urease inhibitors with antibacterial and/or antiprotozoal activity.
Career Highlights
Throughout his career, Santos has worked with various organizations, including Ems S.A. and Universidade Estadual Paulista Julio De Mesquita Filho (UNESP). His work in these institutions has contributed to his expertise in pharmaceutical innovations.
Collaborations
Santos has collaborated with notable colleagues such as Renato F Menegon and Ednir D Vizioli. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Jean L Santos is a distinguished inventor whose work in developing innovative pharmaceutical compounds has the potential to impact healthcare significantly. His contributions through patents demonstrate his commitment to advancing medical science.